Symbols / ADXN $6.88 +0.00%
ADXN Chart
About
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM); and GABAB PAM for the treatment pain, anxiety, addiction, cough, and overactive bladder. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the develop mGlu2 PAM compounds for the treatment of human health; and license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 8.48M |
| Enterprise Value | 799.86M | Income | -6.20M | Sales | 158.54K |
| Book/sh | 0.06 | Cash/sh | 0.02 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2 | IPO | — |
| P/E | — | Forward P/E | -137.60 | PEG | — |
| P/S | 53.46 | P/B | 107.27 | P/C | — |
| EV/EBITDA | -325.56 | EV/Sales | 5045.23 | Quick Ratio | 1.91 |
| Current Ratio | 2.01 | Debt/Eq | 0.61 | LT Debt/Eq | — |
| EPS (ttm) | -9.05 | EPS next Y | -0.05 | EPS Growth | — |
| Revenue Growth | -15.00% | Earnings | — | ROA | -15.90% |
| ROE | -72.84% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | -14.04% | Profit Margin | 0.00% | Shs Outstand | 1.23M |
| Shs Float | 93.86M | Short Float | 1.14% | Short Ratio | 3.01 |
| Short Interest | — | 52W High | 12.05 | 52W Low | 6.29 |
| Beta | 1.91 | Avg Volume | 4.77K | Volume | 154.00 |
| Target Price | — | Recom | None | Prev Close | $6.88 |
| Price | $6.88 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$6.88
Latest analyst target
3. DCF / Fair value
$-8.76
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$6.88
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-07-31 | up | HC Wainwright & Co. | Neutral → Buy | $30 |
- ADXN Earnings History & Surprises | EPS & Revenue Results | ADDEX THERAPEUTICS LTD (NASDAQ:ADXN) - ChartMill Fri, 13 Mar 2026 07
- (ADXN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily hu, 12 Mar 2026 19
- Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance Wed, 01 Oct 2025 07
- ADXN.SW Addex Therapeutics Ltd (SIX) 09 Mar 2026: Earnings due; liquidity and forecast to watch - Meyka Mon, 09 Mar 2026 12
- 12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga Wed, 11 Mar 2026 21
- ADXN Stock Price, News & Analysis - Stock Titan Fri, 25 Apr 2025 04
- (ADXN) Risk Channels and Responsive Allocation - Stock Traders Daily Sun, 01 Mar 2026 08
- Why Adobe Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket - Benzinga Fri, 12 Sep 2025 07
- Addex Therapeutics (ADXN) Stock Price, News & Analysis - MarketBeat Wed, 16 Sep 2020 02
- Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga Mon, 20 Oct 2025 07
- ADXN Stock Price and Chart — SIX:ADXN - TradingView ue, 25 Jul 2017 21
- Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga hu, 04 Dec 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -4.66M | -1.87M | -10.19M | -15.15M |
| TotalUnusualItems | 17.43K | -317.29K | -264.36K | 211.69K |
| TotalUnusualItemsExcludingGoodwill | 17.43K | -317.29K | -264.36K | 211.69K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -4.91M | -2.50M | -10.80M | -15.35M |
| ReconciledDepreciation | 260.12K | 305.95K | 323.14K | 347.61K |
| EBITDA | -4.65M | -2.19M | -10.45M | -14.94M |
| EBIT | -4.91M | -2.50M | -10.78M | -15.29M |
| NetInterestIncome | 5.62K | 60.10K | 1.30K | -57.69K |
| InterestExpense | 3.55K | 3.87K | 27.95K | 63.01K |
| InterestIncome | 9.16K | 63.96K | 29.25K | 5.32K |
| NormalizedIncome | -4.93M | -2.18M | -10.54M | -15.56M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 7.06M | -10.56M | -20.80M | -15.35M |
| TotalExpenses | 3.16M | 3.86M | 11.96M | 18.42M |
| RentExpenseSupplemental | 35.57K | 47.28K | 37.51K | |
| TotalOperatingIncomeAsReported | -2.76M | -2.24M | -10.54M | -15.51M |
| DilutedAverageShares | 1.40M | 1.23M | 685.30K | 284.33K |
| BasicAverageShares | 817.61K | 619.23K | 376.54K | 284.33K |
| DilutedEPS | 8.40 | -16.80 | -55.20 | -54.00 |
| BasicEPS | 8.40 | -16.80 | -55.20 | -54.00 |
| DilutedNIAvailtoComStockholders | 7.06M | -10.56M | -20.80M | -15.35M |
| NetIncomeCommonStockholders | 7.06M | -10.56M | -20.80M | -15.35M |
| NetIncome | 7.06M | -10.56M | -20.80M | -15.35M |
| NetIncomeIncludingNoncontrollingInterests | 7.06M | -10.56M | -20.80M | -15.35M |
| NetIncomeDiscontinuousOperations | 11.97M | -8.06M | -10.00M | |
| NetIncomeContinuousOperations | -4.91M | -2.50M | -10.80M | -15.35M |
| TaxProvision | 0.00 | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -4.91M | -2.50M | -10.80M | -15.35M |
| OtherIncomeExpense | -2.16M | -317.29K | -264.36K | 211.69K |
| EarningsFromEquityInterest | -2.18M | 0.00 | 0.00 | |
| GainOnSaleOfSecurity | 17.43K | -317.29K | -264.36K | 211.69K |
| NetNonOperatingInterestIncomeExpense | 5.62K | 60.10K | 1.30K | -57.69K |
| InterestExpenseNonOperating | 3.55K | 3.87K | 27.95K | 63.01K |
| InterestIncomeNonOperating | 9.16K | 63.96K | 29.25K | 5.32K |
| OperatingIncome | -2.76M | -2.24M | -10.54M | -15.51M |
| OperatingExpense | 3.16M | 3.86M | 11.96M | 18.42M |
| OtherOperatingExpenses | 856.27K | 870.49K | 808.98K | 1.31M |
| DepreciationAmortizationDepletionIncomeStatement | 192.70K | 11.75K | 8.81K | 347.61K |
| DepreciationAndAmortizationInIncomeStatement | 192.70K | 11.75K | 8.81K | 347.61K |
| DepreciationIncomeStatement | 192.70K | 11.75K | 8.81K | 347.61K |
| ResearchAndDevelopment | 435.19K | 942.71K | 7.88M | 9.01M |
| SellingGeneralAndAdministration | 1.68M | 2.03M | 3.26M | 7.75M |
| GeneralAndAdministrativeExpense | 1.68M | 2.03M | 3.26M | 7.75M |
| OtherGandA | 1.21M | 1.16M | 1.42M | 1.38M |
| InsuranceAndClaims | 225.77K | 628.60K | 1.59M | 1.59M |
| RentAndLandingFees | 35.57K | 47.28K | 37.51K | |
| SalariesAndWages | 242.59K | 238.53K | 253.09K | 4.74M |
| TotalRevenue | 404.10K | 1.61M | 1.42M | 2.92M |
| OperatingRevenue | 404.10K | 1.61M | 1.42M | 2.92M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 86.01M | 89.12M | 38.21M | 11.37M |
| OrdinarySharesNumber | 98.34M | 95.24M | 77.13M | 37.90M |
| ShareIssued | 184.35M | 184.35M | 115.35M | 49.27M |
| TotalDebt | 41.99K | 344.34K | 373.13K | 482.01K |
| TangibleBookValue | 9.68M | 1.15M | 4.91M | 16.93M |
| InvestedCapital | 9.68M | 1.15M | 4.91M | 16.93M |
| WorkingCapital | 2.74M | 1.34M | 4.55M | 17.81M |
| NetTangibleAssets | 9.68M | 1.15M | 4.91M | 16.93M |
| CapitalLeaseObligations | 41.99K | 344.34K | 373.13K | 482.01K |
| CommonStockEquity | 9.68M | 1.15M | 4.91M | 16.93M |
| TotalCapitalization | 9.68M | 1.15M | 4.91M | 16.93M |
| TotalEquityGrossMinorityInterest | 9.68M | 1.15M | 4.91M | 16.93M |
| StockholdersEquity | 9.68M | 1.15M | 4.91M | 16.93M |
| OtherEquityInterest | 64.62M | 64.62M | 64.62M | |
| GainsLossesNotAffectingRetainedEarnings | 31.06M | 29.81M | 25.77M | 24.44M |
| OtherEquityAdjustments | 31.06M | 29.81M | 25.77M | 24.44M |
| TreasuryStock | 869.71K | 909.57K | 6.28M | 11.70M |
| RetainedEarnings | -353.36M | -360.42M | -349.86M | -329.06M |
| AdditionalPaidInCapital | 266.38M | 266.19M | 269.51M | 283.98M |
| CapitalStock | 1.84M | 1.84M | 1.15M | 49.27M |
| CommonStock | 1.84M | 1.84M | 1.15M | 49.27M |
| TotalLiabilitiesNetMinorityInterest | 1.00M | 3.50M | 3.37M | 5.61M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 198.94K | 603.14K | 87.03K | 1.48M |
| EmployeeBenefits | 164.25K | 443.52K | 0.00 | 1.28M |
| NonCurrentPensionAndOtherPostretirementBenefitPlans | 164.25K | 443.52K | 0.00 | 1.28M |
| NonCurrentDeferredLiabilities | 0.00 | 89.23K | 0.00 | |
| NonCurrentDeferredRevenue | 0.00 | 89.23K | 0.00 | |
| LongTermDebtAndCapitalLeaseObligation | 34.69K | 70.38K | 87.03K | 194.32K |
| LongTermCapitalLeaseObligation | 34.69K | 70.38K | 87.03K | 194.32K |
| CurrentLiabilities | 802.09K | 2.89M | 3.28M | 4.13M |
| CurrentDeferredLiabilities | 0.00 | 234.98K | 0.00 | 0.00 |
| CurrentDeferredRevenue | 0.00 | 234.98K | 0.00 | 0.00 |
| CurrentDebtAndCapitalLeaseObligation | 7.31K | 273.96K | 286.11K | 287.70K |
| CurrentCapitalLeaseObligation | 7.31K | 273.96K | 286.11K | 287.70K |
| PayablesAndAccruedExpenses | 794.79K | 2.38M | 3.00M | 3.85M |
| CurrentAccruedExpenses | 518.85K | 1.24M | 1.60M | 1.86M |
| Payables | 275.94K | 1.15M | 1.40M | 1.99M |
| OtherPayable | 120.88K | 203.29K | ||
| TotalTaxPayable | 22.65K | 164.61K | 120.88K | 203.29K |
| AccountsPayable | 253.29K | 984.38K | 1.28M | 1.79M |
| TotalAssets | 10.68M | 4.64M | 8.28M | 22.54M |
| TotalNonCurrentAssets | 7.14M | 407.28K | 453.09K | 600.01K |
| NonCurrentPrepaidAssets | 7.09K | 54.34K | 54.35K | 57.91K |
| InvestmentsAndAdvances | 7.09M | 0.00 | ||
| LongTermEquityInvestment | 7.09M | 0.00 | ||
| InvestmentsinAssociatesatCost | 7.09M | 0.00 | ||
| NetPPE | 42.71K | 352.94K | 398.73K | 542.10K |
| AccumulatedDepreciation | -153.71K | -4.32M | -4.02M | -3.77M |
| GrossPPE | 196.42K | 4.67M | 4.41M | 4.32M |
| Leases | 111.64K | 1.73M | 1.47M | 1.30M |
| OtherProperties | 84.78K | 2.94M | 2.94M | 3.01M |
| MachineryFurnitureEquipment | 0.00 | 7.56K | 7.56K | 7.56K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 3.54M | 4.23M | 7.83M | 21.94M |
| OtherCurrentAssets | 7.97K | |||
| CurrentDeferredAssets | 0.00 | |||
| PrepaidAssets | 169.65K | 217.01K | 270.39K | 1.12M |
| Receivables | 15.51K | 151.27K | 598.32K | 324.42K |
| OtherReceivables | 40.91K | 181.44K | 159.64K | |
| AccountsReceivable | 15.51K | 110.36K | 416.88K | 164.78K |
| CashCashEquivalentsAndShortTermInvestments | 3.35M | 3.87M | 6.96M | 20.50M |
| OtherShortTermInvestments | 6.50K | 848.00 | 3.17K | 17.14K |
| CashAndCashEquivalents | 3.34M | 3.87M | 6.96M | 20.48M |
| CashFinancial | 3.34M | 3.87M | 6.96M | 20.48M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -5.37M | -8.00M | -16.44M | -14.74M |
| RepurchaseOfCapitalStock | -1.76K | -8.95K | -3.49K | -332.00 |
| RepaymentOfDebt | -73.69K | -281.79K | -288.08K | -309.62K |
| IssuanceOfCapitalStock | 240.90K | 2.35M | 1.68M | 13.96M |
| CapitalExpenditure | -1.27K | -6.84K | -581.00 | -31.55K |
| EndCashPosition | 3.34M | 3.87M | 6.96M | 20.48M |
| BeginningCashPosition | 3.87M | 6.96M | 20.48M | 18.70M |
| EffectOfExchangeRateChanges | 99.68K | -356.95K | -196.22K | 122.47K |
| ChangesInCash | -623.42K | -2.73M | -13.33M | 1.67M |
| FinancingCashFlow | 104.92K | 5.26M | 3.10M | 16.40M |
| CashFlowFromContinuingFinancingActivities | 104.92K | 5.26M | 3.10M | 16.40M |
| NetOtherFinancingCharges | -14.85K | -28.74K | -523.11K | -2.65M |
| InterestPaidCFF | -9.22K | -21.61K | -48.90K | -63.01K |
| ProceedsFromStockOptionExercised | -36.46K | 3.26M | 2.29M | 5.47M |
| CashDividendsPaid | 0.00 | 0.00 | 0.00 | 0.00 |
| NetCommonStockIssuance | 239.13K | 2.34M | 1.67M | 13.96M |
| CommonStockPayments | -1.76K | -8.95K | -3.49K | -332.00 |
| CommonStockIssuance | 240.90K | 2.35M | 1.68M | 13.96M |
| NetIssuancePaymentsOfDebt | -73.69K | -281.79K | -288.08K | -309.62K |
| NetLongTermDebtIssuance | -73.69K | -281.79K | -288.08K | -309.62K |
| LongTermDebtPayments | -73.69K | -281.79K | -288.08K | -309.62K |
| InvestingCashFlow | 4.65M | -6.84K | 2.97K | -30.31K |
| CashFlowFromContinuingInvestingActivities | 4.65M | -6.84K | 2.97K | -30.31K |
| NetOtherInvestingChanges | 5.12M | |||
| NetInvestmentPurchaseAndSale | 0.00 | 0.00 | 3.55K | 1.24K |
| SaleOfInvestment | 0.00 | 0.00 | 3.55K | 1.24K |
| NetBusinessPurchaseAndSale | -473.27K | 0.00 | 0.00 | |
| PurchaseOfBusiness | -473.27K | 0.00 | 0.00 | |
| NetPPEPurchaseAndSale | -1.27K | -6.84K | -581.00 | -31.55K |
| PurchaseOfPPE | -1.27K | -6.84K | -581.00 | -31.55K |
| OperatingCashFlow | -5.37M | -7.99M | -16.44M | -14.71M |
| CashFlowFromContinuingOperatingActivities | -5.37M | -7.99M | -16.44M | -14.71M |
| ChangeInWorkingCapital | -1.23M | 213.76K | 157.68K | -761.57K |
| ChangeInOtherWorkingCapital | -38.40K | 324.21K | -820.15K | |
| ChangeInOtherCurrentAssets | -13.62K | 2.32K | 13.98K | 47.78K |
| ChangeInPayablesAndAccruedExpense | -1.15M | -613.21K | -427.39K | 883.84K |
| ChangeInPrepaidAssets | -164.28K | 53.39K | 844.98K | -616.99K |
| ChangeInReceivables | 134.01K | 447.05K | -273.89K | -256.05K |
| ChangesInAccountReceivables | 93.11K | 306.51K | -252.09K | -96.41K |
| OtherNonCashItems | 400.57K | 2.11M | 3.90M | 1.21M |
| StockBasedCompensation | 3.68M | 1.18M | ||
| DepreciationAmortizationDepletion | 260.12K | 305.95K | 323.14K | 347.61K |
| DepreciationAndAmortization | 260.12K | 305.95K | 323.14K | 347.61K |
| Depreciation | 260.12K | 305.95K | 323.14K | 347.61K |
| OperatingGainsLosses | -11.86M | -62.64K | -11.39K | -150.46K |
| PensionAndEmployeeBenefitExpense | -95.22K | -62.64K | -11.39K | -150.46K |
| EarningsLossesFromEquityInvestments | 2.18M | 0.00 | 0.00 | |
| GainLossOnSaleOfPPE | 0.00 | -127.00 | ||
| GainLossOnSaleOfBusiness | -13.94M | 0.00 | 0.00 | |
| NetIncomeFromContinuingOperations | 7.06M | -10.56M | -20.80M | -15.35M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for ADXN
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|